US20100286745A1 - Radially Expandable Gastrointestinal Stimulation Device - Google Patents

Radially Expandable Gastrointestinal Stimulation Device Download PDF

Info

Publication number
US20100286745A1
US20100286745A1 US12699792 US69979210A US2010286745A1 US 20100286745 A1 US20100286745 A1 US 20100286745A1 US 12699792 US12699792 US 12699792 US 69979210 A US69979210 A US 69979210A US 2010286745 A1 US2010286745 A1 US 2010286745A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
fixation device
gastrointestinal
device
sensor
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12699792
Inventor
Mir A. Imran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntraPace Inc
Original Assignee
IntraPace Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

A fixation device for holding stimulating electrodes in electrical contact with the wall of a portion of the gastrointestinal tract is provided. In one embodiment, the fixation device includes an expandable member that fixes the electrodes in electrical contact with the gastrointestinal tract wall. Also provided is an implantable device and method for controlling the opening and/or closing of the pylorus. In particular a device and method is provided for stimulating the duodenum to control the closing/and or opening of the pylorus.
Finally, a method is provided for treating obesity by controlling the pylorus to retain food in the stomach for a desired period of time, among other things to provide a feeling of-satiety and/or to reduce hunger. One aspect includes controlling the pylorus's contraction by electrical stimulation of the duodenum.

Description

    CROSS REFERENCE TO RELATED APPLICATION DATA
  • The present application is a Continuation of U.S. application Ser. No. 11/281,228 filed Nov. 16, 2005 (Allowed), which application is a Divisional of U.S. application Ser. No. 10/691,735 filed Oct. 22, 2003 (now U.S. Pat. No. 7,054,690); the full disclosures of which are incorporated herein by reference in their entirety.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The invention relates to a stimulation device and method for stimulating a portion of the gastrointestinal tract and in one particular embodiment to a device and method for stimulating the duodenum to control the pylorus and/or to treat obesity.
  • 2. Background of the Invention
  • In general when food is ingested into the stomach, initially, the elastic upper portion or fundus accommodates the food and the fundus expands. As food enters and the fundus expands there is a pressure gradient created in the stomach between the fundus and the antrum (fundus pylori). A number of things occur at this time. Fluids tend to be pushed through the pylorus, which acts as a leaky valve. Peristaltic contractions move down the stomach from the fundus into the antrum to mix and break down food and propel small particles through the pylorus into the duodenum. In healthy human stomachs, peristalsis is believed to be controlled at least in part by a region of the stomach identified near the interface of the fundus and the corpus along the greater curvature. In this region, there are cells believed to govern the organs' periodic contractile behavior that generate and propagate rhythmic electrical signals that correspond to the contractile behavior of the stomach. These characteristic contractions are believed to create, a pressure gradient between the fundus pylori (or antrum) and duodenum that relates to the rate of gastric emptying. When the contractions begin, the pylorus is generally closed, although fluid and small particles leak through the valve. As contractions or electrical activity corresponding to the contractions reach pylorus, the pylorus begins to open or relax. Thus, as the stomach churns and breaks down food in a healthy stomach, the pylorus begins to open. As this is occurring, there may be electrical activity in the duodenum as well. Retrograde electrical activity from the duodenum, i.e. contractions or electrical activity in the direction of the pylorus tends to cause the pylorus to close, thus preventing bile and pancreatic juices from backing up into the stomach. Accordingly, the opening and closing of the pylorus is influenced by electrical stimulation input from both of its ends.
  • In a number of disease states or conditions, the contractions of the stomach and/or the opening and closing of the pylorus is irregular. Gastroparesis may result from insufficient contractions to churn food, move food through the pylorus, and/or open the pylorus, among other things, resulting in gastro-retention of food. In another motility disorder known as dumping syndrome, the stomach empties at an abnormally high rate into the small intestine causing various gastrointestinal disorders. It has also been observed that in obese patients, gastric emptying tends to be at a higher than normal rate. It is believed that obesity may be treated by altering gastric motility to cause the stomach to slow gastric emptying.
  • Accordingly, it would be desirable to provide a device and method for controlling gastric emptying. Further, it would be desirable to provide a device and method that controls the contracting and relaxation of the pylorus according to a desired increase or decrease in gastric emptying.
  • Some devices have been proposed to constrict the stomach to reduce stomach volume. These devices are typically implanted in a relatively invasive procedure and operate to constrict the stomach but do not enable periodic control of the stomach emptying. Some devices have been proposed to interfere with the peristaltic motion of the gastrointestinal tract and especially, the stomach, to slow the movement of food from the stomach. These devices control the contractions of the stomach but are not directed to opening and closing the pylorus outside of the context of controlling peristalsis of the stomach. Furthermore, most of these devices require open or laparoscopic surgery in which a stimulator unit is implanted subcutaneously adjacent the abdomen wall with leads extending to the stomach where electrodes are attached. Artificial sphincters, for opening and closing sphincters including the pylorus have been proposed. These devices typically involve placing a constricting member around the sphincters in a relatively invasive procedure.
  • Accordingly it would be desirable to provide a relatively easily implanted device and method for controlling the opening and/or closing of the pylorus. It would further be desirable to provide a method and device for treating obesity.
  • BRIEF SUMMARY OF THE INVENTION
  • The invention provides a fixation device for holding stimulating electrodes in electrical contact with the wall of a portion of the gastrointestinal tract. In one embodiment, the fixation device includes an expandable member that fixes the electrodes in electrical contact with the gastrointestinal tract wall. According to one embodiment, the fixation device comprises a relatively tubular shaped structure that holds stimulating electrodes adjacent the wall of the duodenum while permitting the passage of materials through the device. According to another embodiment of the invention, the fixation device comprises a self-expanding tubular member.
  • The present invention further provides an implantable device and method for controlling the opening and/or closing of the pylorus. In particular, one embodiment comprises a device and method for stimulating the duodenum to control the closing/and or opening of the pylorus. According to this embodiment, electrodes are coupled to the wall of the duodenum. In one embodiment, the electrodes are coupled to the duodenum above the duct through which bile and pancreatic secretions empty into the small intestine. Electrical stimulation pulses are delivered by an electronic circuit through the electrodes. The stimulation pulses that travel in a deep retrograde direction end to cause the pylorus to contract and close. The stimulation may be delivered after sensing a meal or that food has been ingested. For example, detecting a change in temperature due to food particles not at body temperature. Or, the stimulation may be user activated whereby the user turns on the device after ingesting a meal. The stimulation in one embodiment is set to continue for a Predetermined period of time. Thus, where a patient's typical rate of gastric emptying is greater that desired, such emptying may be slowed using the stimulator.
  • The present invention also provides a method for treating obesity by controlling the pylorus to retain food in the stomach for a desired period of time, among other things to provide a feeling of satiety and/or to reduce hunger. According to one embodiment, the pylorus's contraction is controlled by electrical stimulation of the duodenum. The retrograde propagation of the stimulation acts to close or cause contraction of the pylorus.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side cutaway view of a stomach and duodenum with an implanted stimulator according to an embodiment of the invention.
  • FIG. 1A is a side view of the fixation device of the stimulator of FIG. 1 in a compressed configuration.
  • FIG. 1B is a cross sectional view of FIG. 1A along the lines 13-1B.
  • FIG. 1C is a side view of the fixation device of the stimulator of FIG. 1 in an expanded configuration
  • FIG. 1D is a cross-sectional view of FIG. 1C along the lines 1D-1D.
  • FIG. 1E is a top view of a portion of the stimulator illustrated in FIG. 1A.
  • FIG. 1F is a schematic side view of the electrode housing of the stimulator of FIGS. 1, and 1A-1E.
  • FIG. 2 is an alternative electrode housing for the stimulator of FIG. 1 in which electronics are encased in the electrode housing.
  • FIG. 3 illustrates another embodiment of an implanted stimulator according to the invention.
  • FIG. 4 illustrates another embodiment of an implanted stimulator according to the invention.
  • FIG. 4A is a side view of the fixation device of the stimulator of FIG. 4 in an expanded configuration with a removable replaceable battery unit coupled to the electrode housing.
  • FIG. 4B is a side view of the electrode housing and removable battery unit of the stimulator of FIG. 4A.
  • FIG. 4C is an enlarged portion of FIG. 4B as indicated in FIG. 4B.
  • FIG. 5 is a schematic of an electronic circuit of a stimulator according to an embodiment of the invention.
  • FIG. 6 is a schematic of an external controller circuit according to an embodiment of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Referring to FIGS. 1 and 1A-1F a stimulator 30 in accordance with the invention is illustrated implanted in the gastrointestinal tract of a patient. The stimulator 30 comprises a fixation device 34 to be implanted in the duodenum 24 and an electronics housing 50 to be located in the stomach 20 and coupled by wire tube 53 enclosing leads 51, 52, to the fixation device 34. The fixation device 34 includes electrodes 41, 42 in electrical contact with the duodenum 24 and the electronics housing 50 includes electronic circuitry 125 and a battery 144 that supply electrical stimulation pulses to the duodenum 24 through the electrodes 41, 42.
  • In FIG. 1, the fixation device 34 is illustrated in place in the duodenum 24 located adjacent the pylorus 23 of a patient and above the duct 25 (where the ducts for bile and pancreatic secretions merge). The electrodes 41, 42 of the fixation device 34 are contained in an electrode housing 43 (FIG. 1A) and exposed at the outer circumference of the fixation device 34 so that the electrodes 41, 42 may be positioned in electrical contact with the wall 27 of the duodenum 24. The fixation device 34 operates to engage the inner circumference of the wall 27 of the duodenum 24 to hold and maintain the electrodes 41, 42 in electrical contact with the duodenum 24. The fixation device 34 comprises a plurality of rings 36 including undulating members 37 having peaks and valleys that permit compression and expansion of the rings 36.
  • The rings 36 are preferably formed of Nitinol to provide spring-like properties with sufficient radial strength so that they may be compressed and constrained by a catheter containing the fixation device 34, and released from the catheter to expand into an expanded engaging position within a lumen of the gastrointestinal tract. The rings 36 define a common axis 39 extending through the rings 36. The rings 36 are attached to each other by way of the electrode housing 43, which is molded onto the rings 36 along the axis 39 of the rings 36. Each ring 36 is formed by a closed wire loop of undulating members 37 and includes a straight portion 38 over which the electrode housing 43 is molded. The electrode housing 43 may be formed of a biocompatible plastic such as polyurethane or polycarbonate. The fixation device 34 further defines a lumen 45 extending along the axis 39 through which materials from the stomach 20 may pass.
  • The fixation device 34 may be delivered in a compressed configuration to the duodenum 24 through a catheter or the like, containing the fixation device 34 in its compressed state. The fixation device is then expanded into a configuration in which it engages the wall 27 of the duodenum 24. As illustrated in FIGS. 1A and 1B, in a compressed position, the diameter of the fixation device 34 is relatively small so that it can reside with in a catheter of sufficiently small diameter to be placed through upper gastrointestinal tract (i.e., into the mouth of a patient, through the esophagus and stomach, and through the pylorus into the duodenum). The catheter may include a retractable sheath containing the fixation device 34. The sheath is retractable upon locating the catheter in a desirable position for deployment of the fixation device 34 in the duodenum 24. This may be guided by an endoscope or fluoroscopy. The fixation device 34 should be position in an orad location from the duct 25 where the bile and pancreatic secretions empty into the duodenum 24 so that the fixation device 34 does not block the duct 25. When retracted, the sheath permits the self-expanding rings 36 of the fixation device 34 to expand to the expanded position illustrated in FIGS. 1C and 1D. Thus, when released from the catheter, the fixation device 34 expands to engage the inner circumference of the wall 27 of the duodenum 24. In its expanded position, the circumference of the fixation device 34 increases while the electrode housing 43 and the straight portion 38 of each ring 36 encased by the electrode housing 43 maintain their original size and shape. The radial strength of the rings 36 serves to hold the fixation device 34 in place. The electrodes 41, 42 are located on the outer surface 44 of the electrode housing 43 and the rings 36 hold them in place against the wall 27 of the duodenum 24 to provide electrical contact therewith. Alternatively, the rings 36 may be expandable by a balloon catheter or the like.
  • A pair of leads 51, 52 encased in a tube 53 extend out of the fixation device 34 and are coupled to the electronics housing 50—When the fixation device 34 is deployed, the tube 53. and electronics housing 50 extend in an orad direction, through the pylorus 23 and into the stomach 20. The electronics housing 50 is attached to the stomach 20 wall leaving sufficient slack in the tube 53 to allow for stomach contractions and movement. In this embodiment, the electronics housing 50 contains a battery 144 and electronic circuitry 125 (FIG. 5) for providing electrical stimulation to the duodenum 24 through the leads 51, 52 extending thorough tubing 53 and coupled to the electrodes 41, 42. FIG. 5 illustrates exemplary electronics 125 and battery 144 that may be used with the stimulator 30 or stimulators of other embodiments of the invention, such as, for example, those described herein. The electronics housing 50 also includes a sensor 51 (or plurality of sensors) that may be provided with the capability of sensing one or more of various parameters of the gastrointestinal tract such as, e.g., pressure, temperature, pH, and relative movement (e.g., using an accelerometer).
  • The electronics housing 50 may be delivered into the stomach and coupled to the fixation device 34 in a number of manners. With the fixation device 34 in position in the duodenum 24, the electronics housing 50 may be delivered to the stomach and attached to the fixation device through the wire tubing 53 extending between the stomach 20 and the duodenum 24 by connecting the wire tubing of a first portion 53 a attached to the fixation device 34, to a second portion 53 b of the wire tubing 53 coupled to the electronics housing 50. The first portion 53 a has a free end 54 with a connector 55 and an attached end 56 attached to the electrodes 41, 42 through the electrode housing 43 on the fixation device 34.
  • The second portion 53 b includes an attached end 59 coupled to the electronics housing 50 and a free end 57 having a connector 58 that will mate with the connector 55 on the free end 54 of the first portion 53 a to provide a connected electrical leads between the electrode housing 43 and the electronics housing 50. The electronics housing 50 is secured to the stomach wall with an attachment mechanism 52 and so that the tube 53 has sufficient slack to permit stomach churning, while not damaging or pulling the housing 50, fixation device 34 or tube 53. The attachment mechanism 52 prevents the housing 50 from moving through the pylorus 23. The attachment mechanism 52 comprises an elongate flexible member 45 attached to the housing 50 and extending through the stomach wall and having a T-shaped end 46 that attaches the elongate member 45 to the stomach wall.
  • The electronics housing 50 may be delivered into the stomach and attached to the stomach wall using a needle into which the T-shaped end 46 is loaded. The needle pierces the stomach wall and releases the T-shaped end 46. The housing 50 is then attached to the fixation device 34 by using grasping tools extending through tool channels of an endoscope, to attach connectors 55 and 58. The electronics housing 50 may also be detached from the fixation device 34 through connectors 55, 58 so that the battery 144 and/or electronics125 may be replaced. While the electronics housing 50 and fixation device 34 are illustrated as being connected after the fixation device 34 and electrode housing 43 have been deployed, the electronics housing 50 may also be deployed through the catheter in a connected position with the fixation device before or after the fixation device 34 has been positioned and deployed. A catheter accommodating a needle to attach the attachment device 52 and a deployment mechanism for the fixation device 34 would need to be accommodated in a catheter designed for the multiple tasks involved.
  • The electronics housing 50 has a round smooth shape that will minimize any trauma to the stomach. The electronics housing 50 is also of a sufficient size that it will not be passed through pylorus 23 into the duodenum 24. It is further constructed of a material that resists corrosion in the highly acidic stomach environment. Such corrosion resistant materials may include, for example, an acid corrosion resistant material such as a suitable inert polymer, for example, materials from the Polyolefin family like HDPE (high density polyethylene), LLDPE (linear low density polyethylene), and UHMWPE (ultra high molecular weight polyethylene); fluoropolymer materials like PTFE′ (poly tetrafluoroethylene), FEPTM (fluorinated ethylene propylene) and others; polymethylpentene, and polysulphons; some elastomers such as thermoplastic polyurethanes and C-Flex type block copolymers that are stable in acidic environments. Additionally the electronics housing 50 may be constructed of an acid corrosion resistant metal such as Platinum, Gold, Tantalum, Titanium, or suitable alloys thereof.
  • Referring to FIG. 5, the electronics 125 and battery 144 are illustrated that may be used with the various embodiments of the stimulator described herein. The electronic circuitry may be on a chip or otherwise have a standard configuration that may be used in a number of different embodiments of the stimulator device. In general, the electronic circuitry includes a controller that delivers electrical stimulation pulses through the electrodes to the wall of the duodenum, the stimulation tends to cause the pylorus 23 to close. The stimulation may be actuated by a user upon ingesting food and the stimulation may continue for a predetermined period of time thereafter. In one embodiment the stimulation parameters are preprogrammed into the controller. The stimulation device may also be provided with the capability of sensing various parameters of the gastrointestinal tract such as, e.g., pressure, temperature and relative movement (e.g., using an accelerometer). The parameters may be used to determine various conditions, for example, patient is awake, sleeping and the type, period, or other parameters of stimulation may be modified according to a program or by a user or health care provider. The electronic circuitry 125 of the stimulator is located in the stimulator housings of the various implants described herein such as, for example, a subcutaneously implanted stimulator unit; a stimulator unit included with the fixation device; a removable attachable housing that may be attached to the fixation device; or in a another housing located within the gastrointestinal tract (e.g., the stomach) and attached by way of leads to the fixation device. Likewise, the battery 144 that powers the electronic circuitry 125 may be located in a number of different housings in various embodiments and configurations of the stimulator. In these different locations, the battery 144 may be removable and replaceable with the electronic circuitry 125 or on its own in a modular device. If the stimulator is included with the fixation device, the battery may also be removably and replaceably attachable to the electronics or electrode housing on the fixation device. The battery 144 may be located with the electronic circuitry 125 attached by way of leads to the stimulator.
  • The stimulation of the duodenum occurs for a predetermined period of time after which the stimulation is discontinued to allow emptying of the stomach. The circuitry 125 of one embodiment as illustrated in FIG. 5 comprises: a microprocessor or controller 140 for controlling the operations of the electronic circuitry 125, and an internal clock 141. The circuitry 125 may also include a battery device 144 such as a pair of lithium iodine batteries for powering the various components of the circuitry 125. Alternatively, the battery device 144 may be housed in a separate unit that may be coupled to the circuitry 125. As such, the controller 140 and battery device 144 are coupled to each of the major components of the circuit as would be apparent to one of ordinary skill in the art. The controller 140 is coupled to stimulation driver 142, which is coupled to stimulating electrodes 41, 42 (or any of the other electrodes described herein) that are used to provide electrical stimulation in accordance with programmed parameters.
  • The controller 140 is coupled to ROM 143, which contains the program instructions for the controller 140 and any other permanently stored information that allows the microprocessor/controller 140 to operate. The controller 140 addresses memory in ROM 143 through address bus 143 a and the ROM 143 provides the stored program instruction to the controller 140 via data bus 143 b. The controller 140 controls the RF coil 145, which communicates with an external control or programming device 160 (FIG. 6), preferably via a modulated RF signal. Processor 140 is coupled to a buffered oscillator 151 that provides an RF signal to be emitted from the RF coil 145. The RF signal is preferably at about 100 kHz to 5 MHz so that the signal is efficiently transmitted through tissue. The controller 140 controls the oscillator 151 and may provide data to be modulated with the RF signal to be delivered through the RF coil 145. Such data may include, for example, data sensed by a sensor 51 located on the electronics housing 50 (or alternatively the fixation device 34), such as pressure, pH, temperature, movement (accelerometer), or sensed electrical information such as impedance, electrical activity (EMG) etc. One or more sensors 147 a (e.g., accelerometer), 147 b (e.g., pressure), 147 c (e.g., pH), 147 d temperature, or electrodes—41, 42 (for sensing EMG, EGG, or impedance as well as providing stimulation), may be coupled to the controller 140 through A/D converters (with amplifiers) 146 a, 146 b, 146 c, 146 d, 146 e which convert a representative analog electrical signal into a digital signal. Suitable types of these sensors are generally known in the art and may be located within, on, or external to the electronics housing 50, fixation device 34 or electrode housing 43 on the fixation device 44. When the RF coil 145 is receiving an external telemetry signal, the buffered oscillator 151 is disabled. Telemetry signals received on the RF coil 145 are detected in a detector circuit 151 a and to communicated controller 140. The detector circuit 151 a is preferably selected based on the modulation used for telemetry signals. The sensed parameters may indicate e.g. the ingestion of food or activity level of a patient. Pacing may be turned on or off based on these parameters.
  • Controller 140 is coupled to RAM 150 via an address bus 150 a for addressing a location in RAM 150 and a bi-directional data bus 150 b for delivering information to and from RAM 150. The RAM 150 includes event memory 148 that temporarily stores data recorded by sensors 147 a-d or electrodes 41, 42 (or other—electrode pairs described herein). RAM 150 also includes a programmable memory 149 which may be programmed, for example, by an external programmer 160. The data stored in the programmable memory may include specifications for the electrical stimulation operating modes or parameters. Such programming may be done in response to sensed information or it may be done automatically by an external controller or as desired by a treating physician, etc. Sensed data acquired from sensors 147 a-d and electrodes 41, 42 or other electrode pairs described herein, provided to the controller 140 may be stored in event memory 148 in the RAM 150. The data stored in the event memory 148, may be sent intermittently as data bursts via the RF coil 145, as opposed to continuously in order to save battery power.
  • The electrode 41, 42 outputs are used to provide electrical stimulation delivered through the stimulation driver 142 to the electrode 41, 42. The stimulation modes and parameters may be pre-programmed or may be set using the external programmer 160 or in response to sensory feedback. The same electrode outputs may be used to sense impedance through impedance circuit 153 and to sense electrical activity, which is delivered through A/D converter 146 e. The electrodes 41, 42 are coupled through coupling capacitors 155 a and 155 b respectively, to the output of electrical stimulation driver 142 and the inputs of A/D converters 146 e, 146 f.
  • The impedance circuit 153 comprises a constant current source oscillator 154 that oscillates at a frequency of 50-100 kHz, and an A/D converter 146 f coupled to the controller 140. The oscillator 154 provides a constant current source through electrodes 41, 42 resulting in a voltage across the electrodes 41, 42 that is representative of impedance, in view of the constant current. The voltage is provided through and is converted by A/D converter 146 f to a digital signal representative of impedance. A/D converter 146 f has a bandwidth that includes the 50 kHz frequency signal while filtering out the electrical stimulation signal that is delivered to the electrodes 41, 42 through electrical stimulation driver 142, and the EMG signal that is sensed by the electrodes 41, 42. Both of the outputs are filtered out by A/D converter 146 f A/D converter 146 e has a bandwidth that filters out the 50-100 kHz signal. Further, when a stimulation signal is being delivered, the controller 140 does not receive signals from A/D converters 146 e and 146 f. Thus the EMG and impedance sensing functions and the stimulation delivery functions are separated through the electronic circuitry 1-25, though using the same electrodes.
  • The battery 144 has its output supplied to a DC-to-DC converter 144 a to provide a higher voltage, which is utilized for electrical stimulation pulses. The DC-to-DC converter 144 a is conventional and provides an output voltage of 15 to 20 volts.
  • FIG. 6 illustrates the electronic circuitry 163 for external programmer 160. The electronic circuitry 163 comprises: a microprocessor or controller 170 for controlling the operations of the electronic circuitry, an internal clock 171, and a power source 174 such as a battery device for powering the various components of the circuit 163. As such, the controller 170 and battery device 174 are coupled to each of the major components of the circuit as would be apparent to one of ordinary skill in the art. The controller 170 may be coupled to a speaker 167 for that provides audible alerts and a display 166 such as a CRT to display data such as recorded data, sensed parameters, treatment parameters and status of the device (e.g. position or battery charge status). The controller 170 is coupled through a buffer 164 to external input device 165 that is used to provide program parameter ‘input, e.g. from a user, for a user to request data displayed in a desired format through display 166 or speaker 167, or to turn the device on and off. The external programmer 160 is also provided with an external data port 168 to interface with a computer and provide a means for bi-directional communication of data or commands. The computer may provide programming or data to the controller/microprocessor 170. A user may also interface with the computer to provide treatment protocols or changes in protocols, etc. Also, a user may control the turning on and off of the stimulation program.
  • The controller 170 is coupled to ROM 173, which contains the program-instructions for the controller 170 and any other permanently stored information that allows the microprocessor/controller to operate. The controller 170 addresses memory in ROM 173 through address bus 173 a and the ROM 173 provides the stored program instructions to the controller 170 via data bus 173 b. The controller 170 controls the RF coil 175, which communicates with stimulator electronic circuitry 125 (FIG. 5) through its RF coil 145. Processor 170 is coupled to an oscillator 172 that provides an RF signal, preferably having a characteristic frequency of 500 kHz or higher, to be emitted from the RF coil 175. The controller 170 controls the oscillator 172 and provides data to be modulated with the RF signal, for example, programming information, stimulation parameters, etc. The RF coil 175 also receives information transmitted via RF signal from RF coil 145 on the stimulator electronic circuitry 125 such as various sensed data, e.g., pressure, pH, impedance, electrical activity (EMG) etc. The received RF signal is passed through demodulator 176 and is transmitted to the controller 170. The data is delivered to the event memory 178 in RAM 177 by way of data bus 177 b for temporary storage. The data may be retrieved from RAM 177 by addressing the storage location via the address bus 177 a.
  • Event memory 178 temporarily stores data recorded by sensors 147 a-147 e and electrodes 41, 42 and delivered via telemetry to the external programmer 160, until the data is downloaded onto a computer using the external data port 168. The RAM 177 also includes a programmable memory 179 which may be programmed, for example, to specify operating modes such as waveform, frequency, etc. which programming is then telemetrically communicated to the stimulator electronic circuitry 125. The modes and parameters can either be set using an external programmer 160 or set in response to sensory feedback.
  • In an alternative embodiment, the device includes a housing, electrodes and minimal electronics and an electromagnetic coil. This device is powered by an external electromagnetic coil, which is placed on the patient's abdomen near the implanted device. The electrical stimulation parameters are controlled real-time by an external unit.
  • Referring to FIG. 2, an alternative stimulator 70 having an alternative electronics/electrode housing 73 is illustrated. The stimulator 70 comprises a fixation device 75 with a housing 73 for the electrodes 81, 82. The fixation device 75 is similar to fixation device 34 described above with reference to FIGS. 1-1F. The housing 73 in this embodiment also contains the electronics 125. The electrodes 81, 82 are coupled to the electronic circuitry 125 by way of connectors 83, 84. The electronic circuitry 125 is coupled to leads 76, 77 encased in corrosion resistant wire tubing 78 that extends out of the housing 73 and fixation device 75. When the stimulation device 70 is deployed in the duodenum 24, wire tubing 78 similarly extends out of the duodenum 24 in an orad direction, through the pylorus 23 and into the stomach 20—where it is coupled to the battery 144 contained in a battery housing. The fixation device 75 is placed in the duodenum 24 in a manner similar to fixation device 34 described above with reference to FIGS. 1-1F. The battery housing 74 is configured similarly to the electronics housing 50 of FIGS. 1-1F of a corrosion resistant material and rounded configuration, with the battery 144 but without the electronic circuitry 125. The battery 144 is electrically coupled through leads 76, 77 to the electronic circuitry 125 located in the housing 73. The battery housing 74 is removable and replaceable in a manner similar to electronics housing 50 described above with reference to FIGS. 1-1F and the stimulation-programming and protocol may be delivered in a similar manner as well.
  • Referring to FIG. 3 an alternative stimulator 30′ is illustrated comprising a fixation device 34′ implanted in a duodenum 24 in a similar manner as fixation device 34 described above with reference to FIGS. 1-1F. In this embodiment however, the wire tubing 53′ extends out of the wall 27 of the duodenum 24, into the abdominal cavity 28 where it is coupled to electronics housing 50′ containing the electronics unit 125 and battery 144. In implanting the stimulator 30′, the fixation device 34′ is placed in the duodenum 24 and the electronics housing 50′ is implanted subcutaneously within the abdominal cavity 28. The wire tubing 53′ coupled to and extending from the electronics housing 50′ is then laparoscopically placed through the abdomen and through the wall 27 of the duodenum 24 where it is coupled through connector 44′ to the electrodes 41′, 42′ encased in the electrode housing 43′. The stimulation is provided from the electronic circuitry 125 to the inner wall of the duodenum 24 wall in a manner similar to that described above with reference to FIGS. 1-1F, 5 and 6.
  • Referring to FIG. 3 an alternative stimulator 30′ is illustrated comprising a fixation device 34′ implanted in a duodenum 24 in a similar manner as fixation device 34 described above with reference to FIGS. 1-1F. In this embodiment however, the wire tubing 53′ extends out of the wall 27 of the duodenum 24, into the abdominal cavity 28 where it is coupled to electronics housing 50′ containing the electronics unit 125 and battery 144. In implanting the stimulator 30′, the fixation device 34′ is placed in the duodenum 24 and the electronics housing 50′ is implanted subcutaneously within the abdominal cavity 28. The wire tubing 53′ coupled to and extending from the electronics housing 50L—is then laparoscopically placed through the abdomen and through the wall 27 of the duodenum 24 where it is coupled through connector 44′ to the electrodes 41′, 42′ similarly encased in the electrode housing 43′ as electrodes 41, 42 are encased in housing 43 with reference to FIGS. 1, and 1A-1F. The stimulation is provided from the electronic circuitry 125 to the inner wall of the duodenum 24 wall in a manner similar to that described above with reference to FIGS. 1-1F, 5 and 6.
  • Referring to FIGS. 4, and 4A-4C, an alternative embodiment of the invention is illustrated. A stimulator 90 comprises a fixation device 93 including an electronics housing 94 with electrodes 91, 92 and electronic circuitry 125 coupled to the electrodes 91, 92. The electronic circuitry 125 is powered by battery 144 contained in a removable battery housing 95 that is configured to be removably coupled to the fixation device 93 in electrical communication with the electronics unit 125 contained in the electronics housing 94.
  • In particular, the battery housing 95 includes magnets 98, 99 that may be coupled with magnets 104, 105 on the inner wall 106 of the electronics housing 94. Electrical contacts 96, 97 on the battery housing 95 align with electrical contacts 102, 103 on the inner wall 106 of the electronics housing 94 when the magnets 98, 99 are correspondingly aligned with magnets 104, 105 on the electronics housing 94. When the magnets 98, 99 are aligned with magnets 104, 105 and the battery housing is coupled to the electronics housing 94, contacts 96, 97 are correspondingly electrically coupled to contacts 102, 103 so that the battery 144 provides power to the electronic circuitry 125 among other things, to deliver stimulating pulses to the duodenum 24 as described herein with reference to FIGS. 5 and 6. As shown in FIG. 4C, contact 96 comprises a protruding portion 107 that is positioned in recess 108 in inner wall 106 in electronics housing 94. Contact 102 engages protruding member 107 so that electrical contact is made with contact 96. O-ring 109 seals electrical contacts within recess 108.
  • While the invention has been described with reference to particular embodiments, it will be understood to one skilled in the art that variations and modifications may be made in form and detail without departing from the spirit and scope of the invention.

Claims (17)

  1. 1. A gastrointestinal stimulation device comprising:
    a fixation device comprising a radially expandable member; an outer portion; and
    at least one electrode coupled to the outer portion of the fixation device,
    wherein the radially expandable member is configured to fix the fixation device within a portion of the gastrointestinal tract so that the at least one electrode is in electrical contact with the gastrointestinal tract.
  2. 2. The gastrointestinal stimulation device of claim 1 comprising at least one sensor coupled to the fixation device.
  3. 3. The gastrointestinal stimulation device of claim 2 wherein the at least one sensor comprises at least one of a pressure sensor, an accelerometer, a pH sensor, an impedance sensor, a temperature sensor, or an electrical sensor.
  4. 4. The gastrointestinal stimulation device of claim 3 wherein the pressure sensor comprises a strain gage.
  5. 5. The gastrointestinal stimulation device of claim 4 wherein the pressure sensor measures contractions and distention in the gastrointestinal tract.
  6. 6. The gastrointestinal stimulation device of claim 4 wherein the pressure sensor measures contractions and distention in a duodenum.
  7. 7. The gastrointestinal stimulation device of claim 4 wherein the pressure sensor measures contractions and distention in an antrum.
  8. 8. The gastrointestinal stimulation device of claim 4 wherein the pressure sensor detects a human body's satiety.
  9. 9. The gastrointestinal stimulation device of claim 3 wherein the accelerometer measures a function in gastrointestinal tract.
  10. 10. The gastrointestinal stimulation device of claim 3 wherein the pH sensor detects the pH of chemicals secreted in a duodenum are secreted in the duodenum during at least one of an onset of hunger or an onset of eating.
  11. 11. The gastrointestinal stimulation device of claim 9 wherein the impedance sensor comprises an impedance spectrometer.
  12. 12. The gastrointestinal stimulation device of claim 11 wherein the impedance spectrometer measures chemical constituents of an ingested material.
  13. 13. The gastrointestinal stimulation device of claim 3 wherein the temperature sensor measures temperature changes in the gastrointestinal tract, such that such that a temperature signal from the sensor is indicative of ingested liquid material within the gastrointestinal tract.
  14. 14. The gastrointestinal stimulation device of claim 3 wherein the electrical sensor comprises at least one of an electromyogram (EMG) sensor or electrogastrogram (EGG) sensor.
  15. 15. A gastrointestinal stimulation device comprising:
    a fixation device comprising:
    a radially expandable member;
    an outer portion; and
    at least one electrode coupled to the outer portion of the fixation device, wherein the radially expandable member is configured to fix the fixation device within a portion of the gastrointestinal tract so that the at least one electrode is in electrical contact with the gastrointestinal tract;
    at least one sensor coupled to the fixation device, the at least one sensor comprising a pressure sensor, wherein the pressure sensor comprises a strain gage.
  16. 16. A method for treating a gastrointestinal tract of a patient, the method comprising:
    affixing an fixation device within a lumen of the gastrointestinal tract by introducing the fixation device within the lumen, radially expanding a member of the fixation device so that an outer portion of the fixation device engages the surrounding gastrointestinal tract; and
    sensing a pressure of the gastrointestinal tract with at least one sensor coupled to the fixation device, by measuring a strain of the fixation device with a strain gage.
  17. 17. The method of claim 16, wherein at least one electrode of the fixation device is coupled to the outer portion of the fixation device so that the at least one electrode is in electrical contact with the gastrointestinal tract when the fixation device is expanded therein, and further comprising stimulating the gastrointestinal tract with the electrode.
US12699792 2003-10-22 2010-02-03 Radially Expandable Gastrointestinal Stimulation Device Abandoned US20100286745A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10691735 US7054690B2 (en) 2003-10-22 2003-10-22 Gastrointestinal stimulation device
US11281228 US7676270B2 (en) 2003-10-22 2005-11-16 Radially expandable gastrointestinal stimulation device
US12699792 US20100286745A1 (en) 2003-10-22 2010-02-03 Radially Expandable Gastrointestinal Stimulation Device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12699792 US20100286745A1 (en) 2003-10-22 2010-02-03 Radially Expandable Gastrointestinal Stimulation Device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11281228 Continuation US7676270B2 (en) 2003-10-22 2005-11-16 Radially expandable gastrointestinal stimulation device

Publications (1)

Publication Number Publication Date
US20100286745A1 true true US20100286745A1 (en) 2010-11-11

Family

ID=34521925

Family Applications (4)

Application Number Title Priority Date Filing Date
US10691735 Expired - Fee Related US7054690B2 (en) 2003-10-22 2003-10-22 Gastrointestinal stimulation device
US11281041 Active 2024-06-04 US7430450B2 (en) 2003-10-22 2005-11-16 Device and method for treating obesity
US11281228 Expired - Fee Related US7676270B2 (en) 2003-10-22 2005-11-16 Radially expandable gastrointestinal stimulation device
US12699792 Abandoned US20100286745A1 (en) 2003-10-22 2010-02-03 Radially Expandable Gastrointestinal Stimulation Device

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US10691735 Expired - Fee Related US7054690B2 (en) 2003-10-22 2003-10-22 Gastrointestinal stimulation device
US11281041 Active 2024-06-04 US7430450B2 (en) 2003-10-22 2005-11-16 Device and method for treating obesity
US11281228 Expired - Fee Related US7676270B2 (en) 2003-10-22 2005-11-16 Radially expandable gastrointestinal stimulation device

Country Status (4)

Country Link
US (4) US7054690B2 (en)
EP (1) EP1682216A4 (en)
CA (1) CA2543209A1 (en)
WO (1) WO2005041749A3 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012078924A1 (en) * 2010-12-08 2012-06-14 Intrapace, Inc. Event evaluation using heart rate variation for ingestion monitoring and therapy
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
ES2435094T3 (en) 2000-05-19 2013-12-18 C.R. Bard, Inc. Device and method for capturing and suture tissue
US8761903B2 (en) * 2000-10-11 2014-06-24 The Board Of Regents Of The University Of Texas Gastrointestinal electrical stimulation
EP1272250A4 (en) * 2000-04-11 2003-07-09 Univ Texas Gastrointestinal electrical stimulation
US8467874B2 (en) * 2000-04-11 2013-06-18 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
WO2002013854A1 (en) * 2000-08-11 2002-02-21 Temple University Of The Commonwealth System Of Higher Education Obesity controlling method
US7737109B2 (en) * 2000-08-11 2010-06-15 Temple University Of The Commonwealth System Of Higher Education Obesity controlling method
US6600953B2 (en) 2000-12-11 2003-07-29 Impulse Dynamics N.V. Acute and chronic electrical signal therapy for obesity
CN100366310C (en) * 2001-01-05 2008-02-06 超治疗股份有限公司 Regulation of eating habits
JP4246998B2 (en) * 2001-04-18 2009-04-02 インパルス ダイナミックス エヌヴィ Analysis of eating habits
WO2007047411A3 (en) * 2005-10-12 2007-09-20 Intrapace Inc Systems and devices for stimulating an organ wall
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US7979127B2 (en) * 2001-05-01 2011-07-12 Intrapace, Inc. Digestive organ retention device
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
DE60331457D1 (en) 2002-08-28 2010-04-08 Allergan Inc Fatigue-resistant gastric belt device
US7695446B2 (en) 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
CA2512203C (en) 2002-12-02 2012-10-23 Gi Dynamics, Inc. Bariatric sleeve
US7025791B2 (en) * 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7844338B2 (en) 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
US7613515B2 (en) * 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
US7444183B2 (en) * 2003-02-03 2008-10-28 Enteromedics, Inc. Intraluminal electrode apparatus and method
US20040220682A1 (en) * 2003-03-28 2004-11-04 Gi Dynamics, Inc. Anti-obesity devices
EP1610719B1 (en) * 2003-03-28 2010-01-13 GI Dynamics, Inc. Sleeve for delayed introduction of enzymes into the intestine
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8821521B2 (en) * 2003-07-28 2014-09-02 Baronova, Inc. Gastro-intestinal device and method for treating addiction
US9498366B2 (en) * 2003-07-28 2016-11-22 Baronova, Inc. Devices and methods for pyloric anchoring
US20090259236A2 (en) * 2003-07-28 2009-10-15 Baronova, Inc. Gastric retaining devices and methods
US8048169B2 (en) * 2003-07-28 2011-11-01 Baronova, Inc. Pyloric valve obstructing devices and methods
US9700450B2 (en) 2003-07-28 2017-07-11 Baronova, Inc. Devices and methods for gastrointestinal stimulation
US7054690B2 (en) * 2003-10-22 2006-05-30 Intrapace, Inc. Gastrointestinal stimulation device
CA2588727C (en) * 2003-11-28 2014-01-14 University Technologies International Inc. Gastrointestinal motility control
EP1708641A1 (en) 2003-12-09 2006-10-11 GI Dynamics, Inc. Intestinal sleeve
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
EP2399528B1 (en) 2004-01-23 2013-01-09 Allergan, Inc. Releasably-securable one-piece adjustable gastric band
US8588930B2 (en) * 2005-06-07 2013-11-19 Ethicon, Inc. Piezoelectric stimulation device
US8751003B2 (en) 2004-02-11 2014-06-10 Ethicon, Inc. Conductive mesh for neurostimulation
US7979137B2 (en) 2004-02-11 2011-07-12 Ethicon, Inc. System and method for nerve stimulation
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
US9060835B2 (en) 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US8585771B2 (en) * 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
WO2005087147A1 (en) 2004-03-08 2005-09-22 Endoart S.A. Closure system for tubular organs
US20050209653A1 (en) * 2004-03-16 2005-09-22 Medtronic, Inc. Intra-luminal device for gastrointestinal electrical stimulation
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US8236023B2 (en) 2004-03-18 2012-08-07 Allergan, Inc. Apparatus and method for volume adjustment of intragastric balloons
EP1768618B1 (en) * 2004-07-09 2011-04-20 GI Dynamics, Inc. Devices for placing a gastrointestinal sleeve
US8612016B2 (en) * 2004-08-18 2013-12-17 Metacure Limited Monitoring, analysis, and regulation of eating habits
EP1799145B1 (en) 2004-09-17 2016-12-21 GI Dynamics, Inc. Gastrointestinal anchor
US20060089709A1 (en) * 2004-10-21 2006-04-27 Helmus Michael N Medical implant with average surface charge density
WO2006068970A3 (en) * 2004-12-21 2007-01-18 Mitchell Roslin Anastomotic outlet revision
US7771382B2 (en) * 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US7766973B2 (en) * 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
EP1890763A4 (en) * 2005-06-02 2017-05-03 Metacure Limited Gi lead implantation
WO2007080595A3 (en) * 2006-01-12 2009-04-16 Yuval Elovici Electrode assemblies, tools, and methods for gastric wall implantation
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
US20060282107A1 (en) * 2005-05-09 2006-12-14 Kiyoshi Hashiba Intragastric device for treating obesity
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
JP2008545508A (en) 2005-06-10 2008-12-18 ウィルソン−クック・メディカル・インコーポレーテッドWilson−Cook Medical Incorporated Ablation catheter
US7672727B2 (en) * 2005-08-17 2010-03-02 Enteromedics Inc. Neural electrode treatment
US7822486B2 (en) * 2005-08-17 2010-10-26 Enteromedics Inc. Custom sized neural electrodes
US7616996B2 (en) * 2005-09-01 2009-11-10 Intrapace, Inc. Randomized stimulation of a gastrointestinal organ
US8442841B2 (en) 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US20090234417A1 (en) * 2005-11-10 2009-09-17 Electrocore, Inc. Methods And Apparatus For The Treatment Of Metabolic Disorders
US8295932B2 (en) * 2005-12-05 2012-10-23 Metacure Limited Ingestible capsule for appetite regulation
CA2634614C (en) * 2005-12-22 2011-07-26 Wilson-Cook Medical Inc. Coiled intragastric member for treating obesity
US8216268B2 (en) * 2005-12-22 2012-07-10 Cook Medical Technologies Llc Intragastric bag for treating obesity
US7798954B2 (en) 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
US20070198039A1 (en) * 2006-01-27 2007-08-23 Wilson-Cook Medical, Inc. Intragastric device for treating obesity
ES2545687T3 (en) * 2006-02-03 2015-09-15 Baronova, Inc. gastrointestinal device
US20090157138A1 (en) * 2006-04-18 2009-06-18 Electrocore, Inc. Methods And Apparatus For Treating Ileus Condition Using Electrical Signals
US20100057178A1 (en) * 2006-04-18 2010-03-04 Electrocore, Inc. Methods and apparatus for spinal cord stimulation using expandable electrode
US20080183237A1 (en) * 2006-04-18 2008-07-31 Electrocore, Inc. Methods And Apparatus For Treating Ileus Condition Using Electrical Signals
US7558629B2 (en) * 2006-04-28 2009-07-07 Medtronic, Inc. Energy balance therapy for obesity management
US20070255154A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Activity level feedback for managing obesity
US8160709B2 (en) 2006-05-18 2012-04-17 Endostim, Inc. Use of electrical stimulation of the lower esophageal sphincter to modulate lower esophageal sphincter pressure
US9020597B2 (en) 2008-11-12 2015-04-28 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US7734341B2 (en) * 2006-06-06 2010-06-08 Cardiac Pacemakers, Inc. Method and apparatus for gastrointestinal stimulation via the lymphatic system
US8126538B2 (en) * 2006-06-06 2012-02-28 Cardiac Pacemakers, Inc. Method and apparatus for introducing endolymphatic instrumentation
US7894906B2 (en) * 2006-06-06 2011-02-22 Cardiac Pacemakers, Inc. Amelioration of chronic pain by endolymphatic stimulation
US20070282376A1 (en) * 2006-06-06 2007-12-06 Shuros Allan C Method and apparatus for neural stimulation via the lymphatic system
US7899541B2 (en) * 2006-06-20 2011-03-01 Ebr Systems, Inc. Systems and methods for implantable leadless gastrointestinal tissue stimulation
US7819836B2 (en) * 2006-06-23 2010-10-26 Gi Dynamics, Inc. Resistive anti-obesity devices
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
US7509175B2 (en) * 2006-08-03 2009-03-24 Intrapace, Inc. Method and devices for stimulation of an organ with the use of a transectionally placed guide wire
EP2056741A2 (en) * 2006-08-23 2009-05-13 Svip 2 LLC Devices and methods for altering eating behavior
US8905999B2 (en) * 2006-09-01 2014-12-09 Cardiac Pacemakers, Inc. Method and apparatus for endolymphatic drug delivery
EP2258277A1 (en) * 2006-10-04 2010-12-08 NDO Surgical, Inc. System for gastric restriction
US9724510B2 (en) 2006-10-09 2017-08-08 Endostim, Inc. System and methods for electrical stimulation of biological systems
US7738961B2 (en) * 2006-10-09 2010-06-15 Endostim, Inc. Method and apparatus for treatment of the gastrointestinal tract
US9345879B2 (en) 2006-10-09 2016-05-24 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US9993639B2 (en) * 2006-10-31 2018-06-12 Medtronic, Inc. Implantable medical elongated member including a tissue receiving fixation cavity
WO2008096362A1 (en) * 2007-02-07 2008-08-14 Duocure, Inc. Duodenal stimulation devices and methods for the treatment of conditions relating to eating disorders
WO2008100974A3 (en) * 2007-02-13 2009-12-30 Sharma Virender K Method and apparatus for electrical stimulation of the pancreatico-biliary system
US8801647B2 (en) * 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US20080281375A1 (en) * 2007-05-07 2008-11-13 Transtimulation Research, Inc. Gastrointestinal stimulator device for digestive and eating disorders
US9364666B2 (en) * 2007-05-07 2016-06-14 Transtimulation Research, Inc. Method of using a gastrointestinal stimulator device for digestive and eating disorders
US8007507B2 (en) * 2007-05-10 2011-08-30 Cook Medical Technologies Llc Intragastric bag apparatus and method of delivery for treating obesity
US20080294228A1 (en) * 2007-05-23 2008-11-27 Cardiac Pacemakers Method and device for controlled stimulation of lymphatic flow
EP2303390A4 (en) * 2008-06-03 2011-11-30 Svip 8 Llc Tissue-anchored devices
EP2157936A2 (en) * 2007-06-04 2010-03-03 Svip 8 Llc Tissue anchorable devices
WO2008157180A1 (en) * 2007-06-13 2008-12-24 E-Pacing, Inc. Implantable devices and methods for stimulation of cardiac and other tissues
EP2170458A1 (en) * 2007-06-13 2010-04-07 E- Pacing, Inc. Implantable devices and methods for stimulation of cardiac or other tissues
US8032222B2 (en) 2007-06-19 2011-10-04 Loushin Michael K H Device for electrically and mechanically stimulating a compartment in a body
US20110137227A1 (en) * 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
US8855770B2 (en) * 2007-07-24 2014-10-07 Betastim, Ltd. Duodenal eating sensor
US7930033B2 (en) * 2007-08-17 2011-04-19 Jianfeng Chen Appendicular and rectal stimulator device for digestive and eating disorders
US8888797B2 (en) * 2007-09-07 2014-11-18 Baronova, Inc. Device for intermittently obstructing a gastric opening and method of use
US8301265B2 (en) 2007-09-10 2012-10-30 Medtronic, Inc. Selective depth electrode deployment for electrical stimulation
US9707392B2 (en) * 2007-10-05 2017-07-18 Uti Limited Partnership Feedback controlled gastro-intestinal stimulation
US20090149879A1 (en) * 2007-12-10 2009-06-11 Dillon Travis E Dynamic volume displacement weight loss device
US8099446B2 (en) * 2007-12-12 2012-01-17 International Business Machines Corporation Digital content searching tool
US7883524B2 (en) * 2007-12-21 2011-02-08 Wilson-Cook Medical Inc. Method of delivering an intragastric device for treating obesity
US8016851B2 (en) * 2007-12-27 2011-09-13 Cook Medical Technologies Llc Delivery system and method of delivery for treating obesity
WO2009094609A1 (en) 2008-01-25 2009-07-30 Sharma Virender K Device and implantation system for electrical stimulation of biological systems
US8192350B2 (en) * 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8565885B2 (en) * 2008-01-30 2013-10-22 The Board Of Regents Of The University Of Texas System Ileal electrical stimulation
US8326439B2 (en) 2008-04-16 2012-12-04 Nevro Corporation Treatment devices with delivery-activated inflatable members, and associated systems and methods for treating the spinal cord and other tissues
US8494623B2 (en) * 2008-06-09 2013-07-23 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for in-vivo physiological monitoring
EP2362762A1 (en) 2008-10-06 2011-09-07 Allergan Medical Sàrl Mechanical gastric band with cushions
US8195297B2 (en) * 2008-10-13 2012-06-05 E-Pacing, Inc. Devices and methods for electrical stimulation of the diaphragm and nerves
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
WO2010075482A8 (en) * 2008-12-27 2011-11-17 John Hancock High specific gravity intragastric device
US20100268297A1 (en) * 2009-02-24 2010-10-21 Hans Neisz Duodenal Stimulation To Induce Satiety
WO2010125570A1 (en) * 2009-04-30 2010-11-04 Svip 2 Llc Devices and methods for treating gastrointestinal and metabolic disorders
US20110004288A1 (en) * 2009-06-12 2011-01-06 Terrance Ransbury Intravascular implantable device having integrated anchor mechanism
CA2773868A1 (en) 2009-09-10 2011-03-17 Intrapace, Inc. Improved diagnostic sensors and/or treatments for gastrointestinal stimulation or monitoring devices
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
DE212011100038U1 (en) 2010-03-05 2012-07-17 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US9044298B2 (en) 2010-04-29 2015-06-02 Apollo Endosurgery, Inc. Self-adjusting gastric band
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US8825164B2 (en) 2010-06-11 2014-09-02 Enteromedics Inc. Neural modulation devices and methods
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
WO2012045030A3 (en) 2010-10-01 2012-08-16 Intrapace, Inc. Feedback systems to enhance obstructive and other obesity treatments, optionally using multiple sensors
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
US8696616B2 (en) 2010-12-29 2014-04-15 Ethicon Endo-Surgery, Inc. Obesity therapy and heart rate variability
WO2012142539A1 (en) 2011-04-14 2012-10-18 Endostim, Inc. Systems and methods for treating gastroesophageal reflux disease
US20130046153A1 (en) 2011-08-16 2013-02-21 Elwha LLC, a limited liability company of the State of Delaware Systematic distillation of status data relating to regimen compliance
US9925367B2 (en) 2011-09-02 2018-03-27 Endostim, Inc. Laparoscopic lead implantation method
US9037245B2 (en) 2011-09-02 2015-05-19 Endostim, Inc. Endoscopic lead implantation method
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
WO2013143599A1 (en) * 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders.
WO2013143600A1 (en) * 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders.
WO2013143612A1 (en) * 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders
JP6335888B2 (en) * 2012-06-14 2018-05-30 オートノミクス メディカル,インコーポレーテッド Device for the diagnosis and treatment of overactive bladder, systems, and methods
US9623238B2 (en) 2012-08-23 2017-04-18 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
CN105073186B (en) * 2013-01-31 2018-07-10 迪格玛医疗有限公司 To reduce neural activity of the organ of the subject systems and methods
US9498619B2 (en) 2013-02-26 2016-11-22 Endostim, Inc. Implantable electrical stimulation leads
US9168000B2 (en) 2013-03-13 2015-10-27 Ethicon Endo-Surgery, Inc. Meal detection devices and methods
EP3351218A1 (en) 2013-03-15 2018-07-25 Baronova, Inc. Locking gastric obstruction device
US9827425B2 (en) 2013-09-03 2017-11-28 Endostim, Inc. Methods and systems of electrode polarity switching in electrical stimulation therapy
US9919152B2 (en) 2014-11-05 2018-03-20 Enterastim, Inc. Conditional gastrointestinal stimulation for improved motility
US9682234B2 (en) 2014-11-17 2017-06-20 Endostim, Inc. Implantable electro-medical device programmable for improved operational life
US9956393B2 (en) 2015-02-24 2018-05-01 Elira, Inc. Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
CN104921724A (en) * 2015-07-17 2015-09-23 中国医学科学院生物医学工程研究所 Gastric emptying simulator for electrical impedance imaging detection
FR3059558A1 (en) * 2016-12-07 2018-06-08 Univ Grenoble Alpes implantable system

Citations (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878905A (en) * 1986-02-07 1989-11-07 Blass Karl G Gastrointestinal module: a nonsurgical implant
US5423872A (en) * 1992-05-29 1995-06-13 Cigaina; Valerio Process and device for treating obesity and syndromes related to motor disorders of the stomach of a patient
US5716392A (en) * 1996-01-05 1998-02-10 Medtronic, Inc. Minimally invasive medical electrical lead
US5876445A (en) * 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US6009877A (en) * 1994-06-24 2000-01-04 Edwards; Stuart D. Method for treating a sphincter
US6205359B1 (en) * 1998-10-26 2001-03-20 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6243607B1 (en) * 1996-09-05 2001-06-05 University Technologies International Inc. Gastro-intestinal electrical pacemaker
US6285897B1 (en) * 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US6327503B1 (en) * 1997-04-30 2001-12-04 Medtronic, Inc Method and apparatus for sensing and stimulating gastrointestinal tract on-demand
US20020013537A1 (en) * 2000-07-19 2002-01-31 Rock Emilio Sacristan Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs
US6355070B1 (en) * 1991-10-09 2002-03-12 Scimed Life Systems, Inc. Medical stents for body lumens exhibiting peristaltic motion
US6366814B1 (en) * 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US20020072780A1 (en) * 2000-09-26 2002-06-13 Transneuronix, Inc. Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity
US6427089B1 (en) * 1999-02-19 2002-07-30 Edward W. Knowlton Stomach treatment apparatus and method
US20020103424A1 (en) * 2001-01-31 2002-08-01 Swoyer John M. Implantable medical device affixed internally within the gastrointestinal tract
US6454785B2 (en) * 2000-02-24 2002-09-24 DE HOYOS GARZA ANDRéS Percutaneous intragastric balloon catheter for the treatment of obesity
US20020161414A1 (en) * 2000-12-11 2002-10-31 Melina Flesler Acute and chronic electrical signal therapy for obesity
US20020165589A1 (en) * 2001-05-01 2002-11-07 Imran Mir A. Gastric treatment and diagnosis device and method
US20020183237A1 (en) * 1997-08-26 2002-12-05 Puskas John D. Methods of performing vagal-induced asystole
US20030014086A1 (en) * 2001-07-14 2003-01-16 Sharma Virender K. Method and apparatus for electrical stimulation of the lower esophageal sphincter
US20030018367A1 (en) * 2001-07-23 2003-01-23 Dilorenzo Daniel John Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20030055463A1 (en) * 1999-04-14 2003-03-20 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US6551304B1 (en) * 1999-12-01 2003-04-22 Abbeymoor Medical, Inc. Magnetic retrieval device and method of use
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US6571127B1 (en) * 1997-07-16 2003-05-27 Impulse Dynamics N.V. Method of increasing the motility of a GI tract
US20030120328A1 (en) * 2001-12-21 2003-06-26 Transneuronix, Inc. Medical implant device for electrostimulation using discrete micro-electrodes
US20030125788A1 (en) * 2001-11-09 2003-07-03 Long Gary L. Self-propelled, intraluminal device with electrode configuration and method of use
US6591137B1 (en) * 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US20030144708A1 (en) * 2002-01-29 2003-07-31 Starkebaum Warren L. Methods and apparatus for retarding stomach emptying for treatment of eating disorders
US6606518B1 (en) * 1999-08-06 2003-08-12 Transneuronix, Inc. Apparatus and process for stimulation of a state of complete continence in the neospincter in the preparation of continent neostomies
US20030195600A1 (en) * 2002-04-12 2003-10-16 Carole Tronnes Implantable medical device with captivation fixation
US20030212439A1 (en) * 2001-03-01 2003-11-13 Schuler Eleanor L. Electrical method to control autonomic nerve stimulation of gastrointestinal tract
US6675809B2 (en) * 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20040015201A1 (en) * 2002-04-22 2004-01-22 Transneuronix, Inc. Process for electrostimulation treatment of obesity
US20040059393A1 (en) * 2001-01-05 2004-03-25 Shai Policker Regulation of eating habits
US20040088022A1 (en) * 2002-07-26 2004-05-06 Transneuronix, Inc. Process for electrostimulation treatment of morbid obesity
US20040093039A1 (en) * 2002-10-25 2004-05-13 Raphael Schumert Gastrointestinal pacemaker
US20040107004A1 (en) * 2002-12-02 2004-06-03 Seedling Enterprises, Llc Bariatric sleeve
US20040133089A1 (en) * 1999-04-07 2004-07-08 Endonetics, Inc. Implantable monitoring probe
US20040147816A1 (en) * 2001-04-18 2004-07-29 Shai Policker Analysis of eating habits
US20040162594A1 (en) * 2001-05-17 2004-08-19 King Gary W. Apparatus and method for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US20040172084A1 (en) * 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US20040236381A1 (en) * 2003-05-19 2004-11-25 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US20040236382A1 (en) * 2003-05-19 2004-11-25 Medtronic, Inc. Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof
US6826428B1 (en) * 2000-04-11 2004-11-30 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US20040249417A1 (en) * 2003-06-04 2004-12-09 Terrance Ransbury Implantable intravascular device for defibrillation and/or pacing
US20050049655A1 (en) * 2003-08-27 2005-03-03 Boveja Birinder R. System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20050065575A1 (en) * 2002-09-13 2005-03-24 Dobak John D. Dynamic nerve stimulation for treatment of disorders
US6895279B2 (en) * 2000-09-15 2005-05-17 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus to treat disorders of gastrointestinal peristalsis
US6895278B1 (en) * 1999-04-14 2005-05-17 Transneuronix, Inc. Gastric stimulator apparatus and method for use
US20050222638A1 (en) * 2004-03-30 2005-10-06 Steve Foley Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders
US20050222637A1 (en) * 2004-03-30 2005-10-06 Transneuronix, Inc. Tachygastrial electrical stimulation
US20060025654A1 (en) * 2002-03-18 2006-02-02 Olympus Corporation Endoscopic system for treating inside of body cavity
US7020526B1 (en) * 2002-05-16 2006-03-28 Ruan Jin Zhao Electronic gastro-intestinal stimulation device
US20060074335A1 (en) * 2002-06-28 2006-04-06 Ilan Ben-Oren Management of gastro-intestinal disorders
US7054692B1 (en) * 2001-06-22 2006-05-30 Advanced Bionics Corporation Fixation device for implantable microdevices
US7054690B2 (en) * 2003-10-22 2006-05-30 Intrapace, Inc. Gastrointestinal stimulation device
US20060116736A1 (en) * 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US7160258B2 (en) * 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US7167750B2 (en) * 2003-02-03 2007-01-23 Enteromedics, Inc. Obesity treatment with electrically induced vagal down regulation
US7209783B2 (en) * 2001-06-15 2007-04-24 Cardiac Pacemakers, Inc. Ablation stent for treating atrial fibrillation
US7326207B2 (en) * 1999-05-18 2008-02-05 Curon Medical, Inc. Surgical weight control device
US7363084B2 (en) * 2002-12-25 2008-04-22 Yoshimochi Kurokawa Device for electrically stimulating stomach

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011804B1 (en) 1997-03-27 2009-08-19 Alfred E. Mann Foundation System of implantable devices for monitoring and/or affecting body parameters
WO2000030534A1 (en) 1998-11-25 2000-06-02 Ball Semiconductor, Inc. Spherically-shaped biomedical ic
EP1272250A4 (en) 2000-04-11 2003-07-09 Univ Texas Gastrointestinal electrical stimulation
WO2002026101A3 (en) 2000-09-29 2002-08-22 Pnina Abramovitz-Shnaider System and method for the control of behavioral disorders

Patent Citations (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878905A (en) * 1986-02-07 1989-11-07 Blass Karl G Gastrointestinal module: a nonsurgical implant
US6355070B1 (en) * 1991-10-09 2002-03-12 Scimed Life Systems, Inc. Medical stents for body lumens exhibiting peristaltic motion
US6305436B1 (en) * 1991-10-09 2001-10-23 Scimed Life Systems, Inc. Medical stents for body lumens exhibiting peristaltic motion
US5876445A (en) * 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5423872A (en) * 1992-05-29 1995-06-13 Cigaina; Valerio Process and device for treating obesity and syndromes related to motor disorders of the stomach of a patient
US6009877A (en) * 1994-06-24 2000-01-04 Edwards; Stuart D. Method for treating a sphincter
US5716392A (en) * 1996-01-05 1998-02-10 Medtronic, Inc. Minimally invasive medical electrical lead
US6243607B1 (en) * 1996-09-05 2001-06-05 University Technologies International Inc. Gastro-intestinal electrical pacemaker
US6327503B1 (en) * 1997-04-30 2001-12-04 Medtronic, Inc Method and apparatus for sensing and stimulating gastrointestinal tract on-demand
US6571127B1 (en) * 1997-07-16 2003-05-27 Impulse Dynamics N.V. Method of increasing the motility of a GI tract
US20020198570A1 (en) * 1997-08-26 2002-12-26 Puskas John D. Apparatus for indirectly stimulating the vagus nerve with an electrical field
US20020183237A1 (en) * 1997-08-26 2002-12-05 Puskas John D. Methods of performing vagal-induced asystole
US6366814B1 (en) * 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US6205359B1 (en) * 1998-10-26 2001-03-20 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6879859B1 (en) * 1998-10-26 2005-04-12 Birinder R. Boveja External pulse generator for adjunct (add-on) treatment of obesity, eating disorders, neurological, neuropsychiatric, and urological disorders
US6427089B1 (en) * 1999-02-19 2002-07-30 Edward W. Knowlton Stomach treatment apparatus and method
US20040133089A1 (en) * 1999-04-07 2004-07-08 Endonetics, Inc. Implantable monitoring probe
US6285897B1 (en) * 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US20030055463A1 (en) * 1999-04-14 2003-03-20 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US6684104B2 (en) * 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US20050113880A1 (en) * 1999-04-14 2005-05-26 Transneuronix, Inc. Gastric stimulator apparatus and method for use
US6895278B1 (en) * 1999-04-14 2005-05-17 Transneuronix, Inc. Gastric stimulator apparatus and method for use
US7326207B2 (en) * 1999-05-18 2008-02-05 Curon Medical, Inc. Surgical weight control device
US6606518B1 (en) * 1999-08-06 2003-08-12 Transneuronix, Inc. Apparatus and process for stimulation of a state of complete continence in the neospincter in the preparation of continent neostomies
US6551304B1 (en) * 1999-12-01 2003-04-22 Abbeymoor Medical, Inc. Magnetic retrieval device and method of use
US6454785B2 (en) * 2000-02-24 2002-09-24 DE HOYOS GARZA ANDRéS Percutaneous intragastric balloon catheter for the treatment of obesity
US20050021101A1 (en) * 2000-04-11 2005-01-27 Jiande Chen Gastrointestinal electrical stimulation
US6826428B1 (en) * 2000-04-11 2004-11-30 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US20020013537A1 (en) * 2000-07-19 2002-01-31 Rock Emilio Sacristan Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs
US6895279B2 (en) * 2000-09-15 2005-05-17 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus to treat disorders of gastrointestinal peristalsis
US20020072780A1 (en) * 2000-09-26 2002-06-13 Transneuronix, Inc. Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity
US6591137B1 (en) * 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US20020161414A1 (en) * 2000-12-11 2002-10-31 Melina Flesler Acute and chronic electrical signal therapy for obesity
US20040044376A1 (en) * 2000-12-11 2004-03-04 Melina Flesler Acute and chronic electrical signal therapy for obesity
US20040059393A1 (en) * 2001-01-05 2004-03-25 Shai Policker Regulation of eating habits
US20020103424A1 (en) * 2001-01-31 2002-08-01 Swoyer John M. Implantable medical device affixed internally within the gastrointestinal tract
US6754536B2 (en) * 2001-01-31 2004-06-22 Medtronic, Inc Implantable medical device affixed internally within the gastrointestinal tract
US20030212439A1 (en) * 2001-03-01 2003-11-13 Schuler Eleanor L. Electrical method to control autonomic nerve stimulation of gastrointestinal tract
US20040147816A1 (en) * 2001-04-18 2004-07-29 Shai Policker Analysis of eating habits
US20020165589A1 (en) * 2001-05-01 2002-11-07 Imran Mir A. Gastric treatment and diagnosis device and method
US6535764B2 (en) * 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
US20040162594A1 (en) * 2001-05-17 2004-08-19 King Gary W. Apparatus and method for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US7209783B2 (en) * 2001-06-15 2007-04-24 Cardiac Pacemakers, Inc. Ablation stent for treating atrial fibrillation
US7054692B1 (en) * 2001-06-22 2006-05-30 Advanced Bionics Corporation Fixation device for implantable microdevices
US7160258B2 (en) * 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US20030014086A1 (en) * 2001-07-14 2003-01-16 Sharma Virender K. Method and apparatus for electrical stimulation of the lower esophageal sphincter
US20030018367A1 (en) * 2001-07-23 2003-01-23 Dilorenzo Daniel John Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20060116736A1 (en) * 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US6675809B2 (en) * 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20030125788A1 (en) * 2001-11-09 2003-07-03 Long Gary L. Self-propelled, intraluminal device with electrode configuration and method of use
US20040172095A1 (en) * 2001-12-21 2004-09-02 David Jenkins Medical implant device for electrostimulation using discrete micro-electrodes
US20030120328A1 (en) * 2001-12-21 2003-06-26 Transneuronix, Inc. Medical implant device for electrostimulation using discrete micro-electrodes
US20030144708A1 (en) * 2002-01-29 2003-07-31 Starkebaum Warren L. Methods and apparatus for retarding stomach emptying for treatment of eating disorders
US20060025654A1 (en) * 2002-03-18 2006-02-02 Olympus Corporation Endoscopic system for treating inside of body cavity
US20030195600A1 (en) * 2002-04-12 2003-10-16 Carole Tronnes Implantable medical device with captivation fixation
US20040015201A1 (en) * 2002-04-22 2004-01-22 Transneuronix, Inc. Process for electrostimulation treatment of obesity
US7020526B1 (en) * 2002-05-16 2006-03-28 Ruan Jin Zhao Electronic gastro-intestinal stimulation device
US20060074335A1 (en) * 2002-06-28 2006-04-06 Ilan Ben-Oren Management of gastro-intestinal disorders
US20040088022A1 (en) * 2002-07-26 2004-05-06 Transneuronix, Inc. Process for electrostimulation treatment of morbid obesity
US20050065575A1 (en) * 2002-09-13 2005-03-24 Dobak John D. Dynamic nerve stimulation for treatment of disorders
US20040093039A1 (en) * 2002-10-25 2004-05-13 Raphael Schumert Gastrointestinal pacemaker
US20040107004A1 (en) * 2002-12-02 2004-06-03 Seedling Enterprises, Llc Bariatric sleeve
US7363084B2 (en) * 2002-12-25 2008-04-22 Yoshimochi Kurokawa Device for electrically stimulating stomach
US7167750B2 (en) * 2003-02-03 2007-01-23 Enteromedics, Inc. Obesity treatment with electrically induced vagal down regulation
US20040172084A1 (en) * 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US20040172085A1 (en) * 2003-02-03 2004-09-02 Beta Medical, Inc. Nerve stimulation and conduction block therapy
US20040176812A1 (en) * 2003-02-03 2004-09-09 Beta Medical, Inc. Enteric rhythm management
US20040172086A1 (en) * 2003-02-03 2004-09-02 Beta Medical, Inc. Nerve conduction block treatment
US20040236382A1 (en) * 2003-05-19 2004-11-25 Medtronic, Inc. Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof
US20040236381A1 (en) * 2003-05-19 2004-11-25 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US20040249417A1 (en) * 2003-06-04 2004-12-09 Terrance Ransbury Implantable intravascular device for defibrillation and/or pacing
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20050049655A1 (en) * 2003-08-27 2005-03-03 Boveja Birinder R. System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
US7054690B2 (en) * 2003-10-22 2006-05-30 Intrapace, Inc. Gastrointestinal stimulation device
US7430450B2 (en) * 2003-10-22 2008-09-30 Intrapace, Inc. Device and method for treating obesity
US7676270B2 (en) * 2003-10-22 2010-03-09 Intrapace, Inc. Radially expandable gastrointestinal stimulation device
US20050222637A1 (en) * 2004-03-30 2005-10-06 Transneuronix, Inc. Tachygastrial electrical stimulation
US20050222638A1 (en) * 2004-03-30 2005-10-06 Steve Foley Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012078924A1 (en) * 2010-12-08 2012-06-14 Intrapace, Inc. Event evaluation using heart rate variation for ingestion monitoring and therapy
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food

Also Published As

Publication number Publication date Type
EP1682216A2 (en) 2006-07-26 application
US20060079944A1 (en) 2006-04-13 application
EP1682216A4 (en) 2009-07-08 application
US20050090873A1 (en) 2005-04-28 application
US20060069413A1 (en) 2006-03-30 application
WO2005041749A2 (en) 2005-05-12 application
US7054690B2 (en) 2006-05-30 grant
CA2543209A1 (en) 2005-05-12 application
WO2005041749A3 (en) 2005-11-24 application
US7430450B2 (en) 2008-09-30 grant
US7676270B2 (en) 2010-03-09 grant

Similar Documents

Publication Publication Date Title
US4987897A (en) Body bus medical device communication system
US6659936B1 (en) Method and apparatus for treating incontinence
US4612934A (en) Non-invasive multiprogrammable tissue stimulator
US5509888A (en) Controller valve device and method
US5690691A (en) Gastro-intestinal pacemaker having phased multi-point stimulation
US20110066254A1 (en) Method for controlling flow in a bodily organ
US20090062826A1 (en) Adaptive device and adaptive method for automatically adapting the stomach opening of a patient
US20110087337A1 (en) Apparatus for controlling flow in a bodily organ
US20040117031A1 (en) Satiation devices and methods
US5263480A (en) Treatment of eating disorders by nerve stimulation
US20010011543A1 (en) Controlled food flow in a patient
US4793353A (en) Non-invasive multiprogrammable tissue stimulator and method
US20100016988A1 (en) Satiation devices and methods
US20090240100A1 (en) Method for controlling flow of intestinal contents in a patient's intestines
US20090198210A1 (en) Device for intermittently obstructing a gastric opening and method of use
US20060074449A1 (en) Intravascular stimulation system with wireless power supply
US20080091255A1 (en) Implantable neurostimulator for modulating cardiovascular function
US20080065167A1 (en) Systems and methods of neuromodulation stimulation for the restoration of sexual function
US20050149141A1 (en) Gastric stimulation for altered perception to treat obesity
US20050143766A1 (en) Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use
US6319191B1 (en) Implantable body fluid flow control device
US6915165B2 (en) Intestine dysfunction treatment apparatus
US6432040B1 (en) Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method
US7236821B2 (en) Chronically-implanted device for sensing and therapy
US5108430A (en) Implantable reservoir adapted to receive and store structural devices therein

Legal Events

Date Code Title Description
AS Assignment

Owner name: INTRAPACE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IMRAN, MIR A.;REEL/FRAME:025518/0403

Effective date: 20060104

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR

Free format text: SECURITY INTEREST;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037150/0419

Effective date: 20151117

AS Assignment

Owner name: INTRAPACE, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, AND ASSIGNEE OF GENERAL ELECTRIC CAPITAL CORPORATION;REEL/FRAME:037328/0632

Effective date: 20151215